Literature DB >> 22038307

The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?

David Adler1, Andreas Lindstrot, Jörg Ellinger, Sebastian Rogenhofer, Reinhard Buettner, Sven Perner, Nicolas Wernert.   

Abstract

Predisposition to develop prostate cancer (PCA) varies among the prostate zones, with the peripheral zone (PZ) more prone to tumor development than the transitional zone (TZ). In view of the fact that molecular differences between the zones may explain this difference, combined with the findings that translocations between TMPRSS2 and several ETS members are frequently observed in PCA, we hypothesized that the ETS family may be crucial to explaining this difference. Normal tissues from the PZ and the TZ of 20 PCA patients were laser microdissected to separate glands from stroma. Two oligo microarrays were performed in order to investigate the variation in ETS family gene expression between the glands and the stroma of the two zones. The ETS members, ELF-3, ELF-5, ERG, ETV-1, ETV-4, ETV-5, ETV-7 and FEV, were found to be differentially expressed. A striking observation was that ERG and ETV-1 were found to be up-regulated in the glands of the PZ compared to the TZ, particularly when considering that ERG and ETV-1 fusions account for 50-80% and 20% of PCA occurrences, respectively. These results indicate that the glands and stroma of the two zones display distinct molecular differences and zonal-specific expression of ETS members. Furthermore, ETS members up-regulated in PCA are already overexpressed in the normal PZ, suggesting that these members play a role in the development and progression of PCA.

Entities:  

Keywords:  transcriptional regulation; stroma; glands; ETS; ERG

Mesh:

Substances:

Year:  2011        PMID: 22038307     DOI: 10.3892/mmr.2011.647

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  20 in total

1.  Molecular differences in transition zone and peripheral zone prostate tumors.

Authors:  Jennifer A Sinnott; Jennifer R Rider; Jessica Carlsson; Travis Gerke; Svitlana Tyekucheva; Kathryn L Penney; Howard D Sesso; Massimo Loda; Katja Fall; Meir J Stampfer; Lorelei A Mucci; Yudi Pawitan; Sven-Olof Andersson; Ove Andrén
Journal:  Carcinogenesis       Date:  2015-04-13       Impact factor: 4.944

2.  Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2.

Authors:  Yiming Wang; Christian Gratzke; Alexander Tamalunas; Beata Rutz; Anna Ciotkowska; Frank Strittmatter; Annika Herlemann; Sophie Janich; Raphaela Waidelich; Chunxiao Liu; Christian G Stief; Martin Hennenberg
Journal:  Br J Pharmacol       Date:  2016-11-01       Impact factor: 8.739

3.  Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864.

Authors:  Y Wang; T Kunit; A Ciotkowska; B Rutz; A Schreiber; F Strittmatter; R Waidelich; C Liu; C G Stief; C Gratzke; M Hennenberg
Journal:  Br J Pharmacol       Date:  2015-05-05       Impact factor: 8.739

4.  Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks.

Authors:  Yohan Sumathipala; Nathan Lay; Baris Turkbey; Clayton Smith; Peter L Choyke; Ronald M Summers
Journal:  J Med Imaging (Bellingham)       Date:  2018-12-15

5.  Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.

Authors:  Qingfeng Yu; Christian Gratzke; Yiming Wang; Annika Herlemann; Christian Maximilian Sterr; Beata Rutz; Anna Ciotkowska; Xiaolong Wang; Frank Strittmatter; Christian G Stief; Martin Hennenberg
Journal:  Br J Pharmacol       Date:  2018-04-29       Impact factor: 8.739

6.  A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate.

Authors:  Qingfeng Yu; Christian Gratzke; Ruixiao Wang; Bingsheng Li; Paul Kuppermann; Annika Herlemann; Alexander Tamalunas; Yiming Wang; Beata Rutz; Anna Ciotkowska; Xiaolong Wang; Frank Strittmatter; Raphaela Waidelich; Christian G Stief; Martin Hennenberg
Journal:  J Biol Chem       Date:  2019-06-26       Impact factor: 5.157

Review 7.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

8.  The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor.

Authors:  Bingsheng Li; Xiaolong Wang; Beata Rutz; Ruixiao Wang; Alexander Tamalunas; Frank Strittmatter; Raphaela Waidelich; Christian G Stief; Martin Hennenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-23       Impact factor: 3.000

9.  Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.

Authors:  Kazuhiro Matsumoto; Hirotaka Akita; Keiichi Narita; Akinori Hashiguchi; Kimiharu Takamatsu; Toshikazu Takeda; Takeo Kosaka; Ryuichi Mizuno; Eiji Kikuchi; Mototsugu Oya; Masahiro Jinzaki
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-02-27       Impact factor: 5.554

10.  Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists.

Authors:  Annabel Spek; Bingsheng Li; Beata Rutz; Anna Ciotkowska; Ru Huang; Yuhan Liu; Ruixiao Wang; Frank Strittmatter; Raphaela Waidelich; Christian G Stief; Martin Hennenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.